MSB 7.69% $1.19 mesoblast limited

Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-118

  1. 2,121 Posts.
    lightbulb Created with Sketch. 568
    “There were 422 deaths reported in the integrated safety database; 229 occurred within 30 days of the last dose of remestemcel-L”

    This is your wonder drug in your only paediatric indication - aGVHD reported by the FDA.

    you are the despicable one for not calling it as it is. but as you always show, you’ll twist words and say that the FDAs action are immoral - beacause it saves kids lives.

    you haven’t bothered to count.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.